Oncology IQ
Test your cancer nursing knowledge with ONCC’s OncologyIQ. ONCC will post a new question, the correct answer, and rationale. Follow us on Twitter to get the OncologyIQ question delivered directly to your Twitter feed. Want more questions like this? Check out ONCC Practice Tests!
A patient is receiving a highly emetogenic chemotherapy regimen. To prevent chemotherapy induced nausea and vomiting, the patient’s regimen should include:
a. a four-drug combination, including mensa.
b. a four-drug combination, including a cannabinoid.
c. a four-drug combination, including haloperidol.
d. a four-drug combination, including a neurokinin-1 antagonist.
Answer
d. a four-drug combination, including a neurokinin-1 antagonist.
Rationale:
Guidelines recommend prophylaxis combination prior to highly emetogenic chemotherapy regimen including a neurokinin-1 antagonist.
Reference:
Olsen, M., LeFebvre, K.B., Walker, S.L., & Prechtel Dunphy, E. (Eds.). (2023). Chemotherapy and immunotherapy guidelines and recommendations for practice (2nd ed.). Oncology Nursing Society pp. 432, 433.